HEALTH● LOWAug 20 · Aug 20, 2026, 12:27 PM
AC Immune gains on early-stage trial data for anti-inflammatory agent
Seeking Alpha Tech
AC Immune's stock gained following the release of early-stage trial data for its anti-inflammatory agent. This news reflects progress in pharmaceutical development and its market impact.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoThe delicate diagnosis of Zulma Lobato affecting her vision: 'There is no possibility'ClarínHEALTH1h agoStudy : Hot Water in Plastic - Lined Paper Cups Releases Millions of Microplastic Particles – NaturalNews . comnaturalnews.com · United StatesHEALTH1h agoUniversity of Maryland doctor explains postpartum psychosiswbaltv.com · United StatesHEALTH1h agoAntioch expands access to opioid treatment and recovery serviceseastbaytimes.com · United States